Skip to content

20-236 - A Safety and Efficacy Study of Oral Venetoclax Tablets and Injectable Azacitidine Versus Best Supportive Care as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy to Evaluate

Status: open

Randomized, Open-label, 2-Arm, Multicenter, Phase 3 Study of Venetoclax and Azacitidine Versus Best Supportive Care as Maintenance Therapy for Patients with Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy (VIALE-M)

Treatment for Oncology - Acute Myeloid Leukemia

Contact Us Or call (251) 445-9834

Description

The trial will evaluate how well venetoclax in combination with azacitidine (AZA) works as compared to best supportive care (BSC) as maintenance therapy in patients with Acute Myeloid Leukemia (AML) in first remission after completion of the first chemotherapy treatment regimen.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

This link will open in a new tab or window.